Eledon Pharmaceuticals (ELDN) Shares Outstanding (2013 - 2026)

Eledon Pharmaceuticals' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $1.5 million for Q4 2020.

• Quarterly Shares Outstanding (Entity) rose 101.46% year-over-year to $1.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $1.5 million (up 101.46% YoY) and the FY2020 annual result came in at $1.5 million, up 101.46% from the prior year.
• Shares Outstanding (Entity) was $1.5 million for Q4 2020 at Eledon Pharmaceuticals, up from $1.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.5 million in Q4 2020 and bottomed at $139731.0 in Q1 2016.
• A 5-year average of $547910.4 and a median of $523074.0 in 2018 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2017 — Shares Outstanding (Entity) gained 0.03% — and 2018, when it soared 208.03%.
• Eledon Pharmaceuticals' Shares Outstanding (Entity) stood at $139773.0 in 2016, then surged by 85.94% to $259888.0 in 2017, then soared by 101.43% to $523494.0 in 2018, then jumped by 37.63% to $720465.0 in 2019, then jumped by 101.46% to $1.5 million in 2020.
• Business Quant data shows ELDN's Shares Outstanding (Entity) at $1.5 million in Q4 2020, $1.3 million in Q3 2020, and $1.1 million in Q2 2020.